關於 CELGENE CORPORATION
Celgene Corporation is an American pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since its acquisition in 2019.
Source: Wikipedia
總部86 Morris Avenue, 07901, Summit, US
成立時間2012
狀態營運中
專利2219 項專利
CRYSTALLINE FORMS OF 3-({[(4R)-7-{METHYL[4-(PROPAN-2-YL)PHENYL]AMINO}-3,4-DIHYDRO-2H-1-BENZOPYRAN-4-YL]METHYL}AMINO)PYRIDINE-4-CARBOXYLIC A…EP4590293A4 · 2026
ASSESSING SUBJECTS HAVING ACUTE ST-ELEVATION MYOCARDIAL INFARCTIONSWO2026120283A1 · 2026
關鍵數據
法律資訊
| 法定名稱 | CELGENE CORPORATION |
|---|---|
| LEI | 4SIHMF0MOSTTL8CD0X64在 GLEIF 上查看 ↗ |
| 登記地址 | 86 Morris Avenue, 07901, Summit, US |
| 狀態 | 營運中 |
來源: GLEIF · 更新於 2026年10月16日